| General Information of This Metabolic Reaction (MR) (ID:
MR008514) |
| Formula |
|
| Reactant |
AP26113 |
Product |
BGB598 |
|
Reactant Info
|
Product Info
|
|
Metabolic Type
|
Oxidation
-
A-Oxidation
|
|
|
|
|
|
|
|
| Other MR(s) Related to The Reactant of This MR |
|
Other MR(s) That Metabolize The Reactant of This MR
|
|
|
| Other MR(s) Related to The Product of This MR |
|
Other MR(s) That Produce The Product of This MR
|
|
|
| References |
| 1 |
Brigatinib: first global approval. Drugs. 2017 Jul;77(10):1131-1135.
|
| 2 |
LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.